Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A second generation, selective, irreversible, monoamine oxidase type B inhibitor has been approved for the treatment of Parkinson's disease (PD).

Rasagiline Tablets(Azilect®)